Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Purpose: To evaluate the addition of cetuximab to neoadjuvant chemotherapy before chemoradiotherapy in high-risk rectal cancer. Patients and Methods: Patients with operable magnetic resonance imaging–defined high-risk rectal cancer received four cycles of capecitabine/oxaliplatin (CAPOX) followed by capecitabine chemoradiotherapy, surgery, and adjuvant CAPOX (four cycles) or the same regimen plus weekly cetuximab (CAPOX+C). The primary end point was complete response (CR; pathologic CR or, in patients not undergoing surgery, radiologic CR) in patients with KRAS/BRAF wild-type tumors. Secondary end points were radiologic response (RR), progression-free survival (PFS), overall survival (OS), and safety in the wild-type and overall populations and a molecular biomarker analysis. Results: One hundred sixty-five eligible patients were randomly assigned. Ninety (60%) of 149 assessable tumors were KRAS or BRAF wild type (CAPOX, n = 44; CAPOX+C, n = 46), and in these patients, the addition of cetuximab did not improve the primary end point of CR (9% v 11%, respectively; P = 1.0; odds ratio, 1.22) or PFS (hazard ratio [HR], 0.65; P = .363). Cetuximab significantly improved RR (CAPOX v CAPOX+C: after chemotherapy, 51% v 71%, respectively; P = .038; after chemoradiation, 75% v 93%, respectively; P = .028) and OS (HR, 0.27; P = .034). Skin toxicity and diarrhea were more frequent in the CAPOX+C arm. Conclusion: Cetuximab led to a significant increase in RR and OS in patients with KRAS/BRAF wild-type rectal cancer, but the primary end point of improved CR was not met.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050 · cited 1×
“systemic recurrence remains a significant problem, occurring in 30% to 40% of patients.(7,8)”
BackgroundRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Self-citationOxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Self-citationK-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER
Heald, R. J., & Ryall, R. D. H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91510-2 · Cited by 2,710
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Maas, M., Nelemans, P. J., Valentini, V., Das, P., Rödel, C., Kuo, L.-J., Calvo, F. A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70172-8 · Cited by 1,945
Douillard, J.-Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4860 · Cited by 1,809
Self-citationBokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8397 · Cited by 1,636
Maughan, T. S., Adams, R. A., Smith, C. G., Meade, A. M., Seymour, M. T., Wilson, R. H., Idziaszczyk, S., Harris, R., Fisher, D., Kenny, S. L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60613-2 · Cited by 960
Aschele, C., Cionini, L., Lonardi, S., Pinto, C., Cordio, S., Rosati, G., Artale, S., Tagliagambe, A., Ambrosini, G., Rosetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4911 · Cited by 763
Gérard, J.-P., Azria, D., Gourgou-Bourgade, S., Martel-Laffay, I., Hennequin, C., Etienne, P.-L., Vendrely, V., François, E., de La Roche, G., Bouché, O., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8376 · Cited by 747
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Hochster, H. S., Hart, L. L., Ramanathan, R. K., Childs, B. H., Hainsworth, J. D., Cohn, A. L., Wong, L., Fehrenbacher, L., Abubakr, Y., Saif, M. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4138 · Cited by 613
Smith, N. J., Barbachano, Y., Norman, A. R., Swift, R. I., Abulafi, A. M., & Brown, G. (2008) · Journal of British Surgery · doi:10.1002/bjs.5917 · Cited by 464
Self-citationFernández-Martos, C., Pericay, C., Aparicio, J., Salud, A., Safont, M., Massuti, B., Vera, R., Escudero, P., Maurel, J., Marcuello, E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8541 · Cited by 438
Chua, Y. J., Barbachano, Y., Cunningham, D., Oates, J. R., Brown, G., Wotherspoon, A., Tait, D., Massey, A., Tebbutt, N. C., & Chau, I. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70381-x · Cited by 319
Self-citationHavenga, K., Enker, W. E., Norstein, J., Moriya, Y., Heald, R. J., van Houwelingen, H. C., & van de Velde, C. J. H. (1999) · European Journal of Surgical Oncology (EJSO) · doi:10.1053/ejso.1999.0659 · Cited by 300
Gérard, J.-P., Chapet, O., Nemoz, C., Romestaing, P., Mornex, F., Coquard, R., Barbet, N., Atlan, D., Adeleine, P., & Freyer, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.045 · Cited by 206
Roh, M. S., Yothers, G. A., O'Connell, M. J., Beart, R. W., Pitot, H. C., Shields, A. F., Parda, D. S., Sharif, S., Allegra, C. J., Petrelli, N. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.3503 · Cited by 194
MRI for Detection of Extramural Vascular Invasion in Rectal Cancer
Smith, N. J., Shihab, O., Arnaout, A., Swift, R. I., & Brown, G. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.08.1298 · Cited by 182
Self-citationRödel, C. M., Arnold, D., Hipp, M., Liersch, T., Dellas, K., Iesalnieks, I., Hermann, R. M., Lordick, F., Hinke, A., Hohenberger, W., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.07.2356 · Cited by 148
Aschele, C., Friso, M. L., Pucciarelli, S., Lonardi, S., Sartor, L., Fabris, G., Urso, E. D. L., Bianco, P. D., Sotti, G., Lise, M., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi212 · Cited by 148
Machiels, J.-P., Sempoux, C. L., Scalliet, P. G. M., Coche, J.-C., Humblet, Y., Cutsem, E. V., Kerger, J. N., Canon, J.-L., Peeters, M., Aydın, S., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl460 · Cited by 147
Varella‐Garcia, M. (2006) · Diagnostic Pathology · doi:10.1186/1746-1596-1-19 · Cited by 124
Horisberger, K., Treschl, A., Mai, S., Miranda, M. B., Kienle, P., Ströbel, P., Erben, P., Woernle, C. M., Dinter, D. J., Kähler, G. F. B. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.014 · Cited by 110
Hofheinz, R., Horisberger, K., Woernle, C. M., Wenz, F. K., Kraus-Tiefenbacher, U., Kähler, G. F. B. A., Dinter, D. J., Grobholz, R., Heeger, S., Post, S., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.005 · Cited by 96
Sebag‐Montefiore, D., Glynne‐Jones, R., Falk, S., Meadows, H. M., & Maughan, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602818 · Cited by 93
Bertolini, F., Chiara, S., Bengala, C., Antognoni, P., Dealis, C., Zironi, S., Malavasi, N., Scolaro, T., Depenni, R., Jovic, G., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.065 · Cited by 84
Rödel, C. M., Becker, H., Fietkau, R., Graeven, U., Hohenberger, W., Hothorn, T., Lang-Welzenbach, M., Liersch, T., Staib, L., Christiansen, H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.18_suppl.lba3505 · Cited by 80
Carraro, S., Roca, E. L., Cartelli, C., Rafailovici, L., Odena, S. C., Wasserman, E., Gualdrini, U. A., Huertas, E., Barugel, M. E., Ballarino, G., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02933-4 · Cited by 75
Tveit, K., Guren, T. K., Glimelius, B. L. G., Pfeiffer, P., Sorbye, H., Pyrhönen, S. O., Kure, E. H., Ikdahl, T., Skovlund, E., & Christoffersen, T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.4_suppl.365 · Cited by 73
Self-citationDekker, J. W. T., Peeters, K. C. M. J., Putter, H., Vahrmeijer, A. L., & van de Velde, C. J. �. (2010) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2010.09.007 · Cited by 69
Cetuximab and chemoradiation for rectal cancer–is the water getting muddy?
Glynne‐Jones, R., Mawdsley, S., & Harrison, M. (2010) · Acta Oncologica · doi:10.3109/02841860903536010 · Cited by 64
Velenik, V., Ocvirk, J., Oblak, I., & Anderluh, F. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2009.12.002 · Cited by 59
Predicting the onset of knee pain: results from a 2-year prospective study of new workers
Jones, G. T., Harkness, E. F., Nahit, E. S., McBeth, J., Silman, A. J., & Macfarlane, G. J. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057570 · Cited by 40
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Conroy, T., Bosset, J.-F., Etienne, P.-L., Rio, E., François, É., Mesgouez-Nebout, N., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00079-6 · Cited by 1,344
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Garcia-Aguilar, J., Chow, O. S., Smith, D. D., Marcet, J. E., Cataldo, P. A., Varma, M. G., Kumar, A. S., Oommen, S., Coutsoftides, T., Hunt, S. R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00004-2 · Cited by 697
Metadata
- Authors
- Dewdney, A., Cunningham, D., Tabernero, J., Capdevila, J., Glimelius, B., Cervantes, A., Tait, D., Brown, G., Wotherspoon, A., Gonzalez de Castro, D., Chua, Y. J., Wong, R., Barbachano, Y., Oates, J., & Chau, I.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-05-10
- Volume
- 30
- Issue
- 14
- Pages
- 1620-1627
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2143847499
- Cited by
- 392
- References
- 40
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.